We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+10.16%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.47B
AUM Growth
+$276M
Cap. Flow
+$43.8M
Cap. Flow %
1.26%
Top 10 Hldgs %
17.35%
Holding
336
New
19
Increased
143
Reduced
127
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 22.02%
2 Healthcare 17.94%
3 Financials 14.72%
4 Consumer Discretionary 13.46%
5 Industrials 12.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDMO
201
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$7.66M 0.22%
408,226
+11,622
+3% +$191K
ZWS icon
202
Zurn Elkay Water Solutions
ZWS
$8.6B
$7.63M 0.22%
357,058
+10,528
+3% +$232K
FOCS
203
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$7.55M 0.22%
145,573
-66,274
-31% -$3.19M
SONO icon
204
Sonos
SONO
$1.78B
$7.55M 0.22%
384,843
+11,337
+3% +$216K
PCRX icon
205
Pacira BioSciences
PCRX
$972M
$7.54M 0.22%
184,695
+5,521
+3% +$220K
CHRS icon
206
Coherus Oncology
CHRS
$187M
$7.3M 0.21%
1,067,184
-50,298
-5% -$390K
DOLE icon
207
Dole
DOLE
$1.22B
$7.22M 0.21%
615,411
-28,560
-4% -$319K
ESTE
208
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$7.21M 0.21%
+553,872
New +$7.43M
ZUO
209
DELISTED
Zuora, Inc.
ZUO
$7.2M 0.21%
728,933
+21,277
+3% +$178K
BPMC
210
DELISTED
Blueprint Medicines
BPMC
$7.18M 0.21%
159,604
+31,362
+24% +$1.41M
CNX icon
211
CNX Resources
CNX
$5.35B
$7.16M 0.21%
446,799
-20,734
-4% -$329K
SKWD icon
212
Skyward Specialty Insurance
SKWD
$2.5B
$7.12M 0.21%
+325,382
New +$6.32M
TMCI icon
213
Treace Medical Concepts
TMCI
$308M
$7.06M 0.2%
+280,178
New +$6.58M
LBRT icon
214
Liberty Energy
LBRT
$3.51B
$7.02M 0.2%
547,937
-25,379
-4% -$375K
PRVA icon
215
Privia Health
PRVA
$2.81B
$7.02M 0.2%
254,198
-20,269
-7% -$535K
CYTK icon
216
Cytokinetics
CYTK
$10.6B
$7.02M 0.2%
199,416
+39,273
+25% +$1.6M
DK icon
217
Delek US
DK
$3.92B
$6.94M 0.2%
302,377
+45,907
+18% +$1.15M
CLVT icon
218
Clarivate
CLVT
$1.22B
$6.91M 0.2%
736,158
+218,095
+42% +$2.25M
HELE icon
219
Helen of Troy
HELE
$682M
$6.89M 0.2%
+72,377
New +$7.75M
ECPG icon
220
Encore Capital Group
ECPG
$1.98B
$6.87M 0.2%
+136,267
New +$7.12M
HZO icon
221
MarineMax
HZO
$1.16B
$6.86M 0.2%
238,643
-10,925
-4% -$343K
VIRT icon
222
Virtu Financial
VIRT
$4.86B
$6.73M 0.19%
356,219
+10,334
+3% +$199K
ATRC icon
223
AtriCure
ATRC
$2.18B
$6.7M 0.19%
161,646
+4,783
+3% +$198K
AXSM icon
224
Axsome Therapeutics
AXSM
$11.3B
$6.68M 0.19%
108,281
+11,895
+12% +$781K
VICR icon
225
Vicor
VICR
$9.72B
$6.63M 0.19%
141,165
+4,174
+3% +$232K

Similar funds

Peregrine Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Peregrine Capital Management held 336 positions worth $3.47B, up 8.7% from $3.19B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Peregrine Capital Management's Q1 2023 filing shows 19 new, 143 increased, 127 reduced and 19 closed positions. Its largest new stake was Synopsys: 50,490 shares worth $19.5M. The largest sale was Texas Capital Bancshares, an estimated $11.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q1 2023 buy was Synopsys: 50,490 shares worth $19.5M.
  • Peregrine Capital Management added most to BILL Holdings in Q1 2023, an estimated $12.1M increase.
  • Peregrine Capital Management's biggest Q1 2023 reduction was Texas Capital Bancshares, cutting an estimated $11.9M.
  • Peregrine Capital Management fully exited NorthWestern Energy in Q1 2023, selling an estimated $11.5M.
  • Peregrine Capital Management's ten largest holdings make up 17% of its $3.47B portfolio in Q1 2023.
  • Peregrine Capital Management opened 19 new positions and closed 19 in Q1 2023.
  • Peregrine Capital Management's portfolio value rose 8.7% quarter-over-quarter to $3.47B.

Based on Peregrine Capital Management's 13F filing for Q1 2023, filed 26 Apr 2023.